Literature DB >> 16721592

Fabry disease and nephrogenic diabetes insipidus.

Philip Wornell1, Sarah Dyack, John Crocker, Weiming Yu, Philip Acott.   

Abstract

Fabry disease is a lysosomal storage disorder with kidney involvement. The initial manifestation of kidney disease is often impaired urinary concentrating ability in adolescence or young adulthood. We describe a boy diagnosed prenatally with Fabry disease who presented with polyuria, polydipsia, hypertension, hypokalaemia and proteinuria at 7 years of age. A formal water-deprivation test followed by vasopressin challenge confirmed nephrogenic diabetes insipidus. A renal biopsy revealed findings typical of Fabry disease. Angiotensin converting-enzyme therapy resulted in rapid improvement of symptoms, normalization of blood pressure and resolution of hypokalaemia and proteinuria. This child is the youngest reported Fabry disease patient with documented renal pathology and clinical manifestations of hypertension, proteinuria and nephrogenic diabetes insipidus.

Entities:  

Mesh:

Year:  2006        PMID: 16721592     DOI: 10.1007/s00467-006-0110-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course.

Authors:  Mary H Branton; Raphael Schiffmann; Sharda G Sabnis; Gary J Murray; Jane M Quirk; Gheona Altarescu; Lev Goldfarb; Roscoe O Brady; James E Balow; Howard A Austin Iii; Jeffrey B Kopp
Journal:  Medicine (Baltimore)       Date:  2002-03       Impact factor: 1.889

Review 2.  Natural history and treatment of renal involvement in Fabry disease.

Authors:  Mary Branton; Raphael Schiffmann; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

3.  The renal lesion in angiokeratoma corporis diffusum.

Authors:  J R COLLEY; D L MILLER; M S HUTT; H J WALLACE; H E DE WARDENER
Journal:  Br Med J       Date:  1958-05-31

4.  The kidney in Fabry disease.

Authors:  Annick Raas-Rothschild; Michael M Friedlaender; Galina Pizov; Rebecca Backenroth
Journal:  J Pediatr       Date:  2005-01       Impact factor: 4.406

5.  [Fetal pathology in Fabry's disease and mucopolysaccharidosis type I].

Authors:  M Elleder; H Poupĕtová; V Kozich
Journal:  Cesk Patol       Date:  1998-01

6.  Early renal changes in hemizygous and heterozygous patients with Fabry's disease.

Authors:  M C Gubler; G Lenoir; J P Grünfeld; A Ulmann; D Droz; R Habib
Journal:  Kidney Int       Date:  1978-03       Impact factor: 10.612

7.  Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies.

Authors:  P Ruggenenti; E Pagano; L Tammuzzo; R Benini; L Garattini; G Remuzzi
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

Review 8.  Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy.

Authors:  Robert J Desnick; Roscoe Brady; John Barranger; Allan J Collins; Dominique P Germain; Martin Goldman; Gregory Grabowski; Seymour Packman; William R Wilcox
Journal:  Ann Intern Med       Date:  2003-02-18       Impact factor: 25.391

9.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Authors:  Markus Ries; Uma Ramaswami; Rossella Parini; Bengt Lindblad; Catharina Whybra; Ingrid Willers; Andreas Gal; Michael Beck
Journal:  Eur J Pediatr       Date:  2003-09-20       Impact factor: 3.183

Review 10.  Renal involvement in Anderson-Fabry disease.

Authors:  Adalberto Sessa; Mietta Meroni; Graziana Battini; Marco Righetti; Alessia Maglio; Antonella Tosoni; Manuela Nebuloni; Gianluca Vago; Ferdinando Giordano
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

View more
  4 in total

Review 1.  Renal complications of Fabry disease in children.

Authors:  Behzad Najafian; Michael Mauer; Robert J Hopkin; Einar Svarstad
Journal:  Pediatr Nephrol       Date:  2012-08-17       Impact factor: 3.714

2.  Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy.

Authors:  P Vylet'al; H Hůlková; M Zivná; L Berná; P Novák; M Elleder; S Kmoch
Journal:  J Inherit Metab Dis       Date:  2008-07-27       Impact factor: 4.982

Review 3.  Recommendations for the diagnosis and management of Fabry disease in pediatric patients: a document from the Rare Diseases Committee of the Brazilian Society of Nephrology (Comdora-SBN).

Authors:  Maria Helena Vaisbich; Luís Gustavo Modelli de Andrade; Cassiano Augusto Braga Silva; Fellype de Carvalho Barreto
Journal:  J Bras Nefrol       Date:  2022 Apr-Jun

4.  Medullary thick ascending limb impairment in the GlatmTg(CAG-A4GALT) Fabry model mice.

Authors:  Hiroki Maruyama; Atsumi Taguchi; Yuji Nishikawa; Chu Guili; Mariko Mikame; Masaaki Nameta; Yutaka Yamaguchi; Mitsuhiro Ueno; Naofumi Imai; Yumi Ito; Takahiko Nakagawa; Ichiei Narita; Satoshi Ishii
Journal:  FASEB J       Date:  2018-03-19       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.